Premenstrual dysphoric disorder
Information
- Disease name
- Premenstrual dysphoric disorder
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT05327075 | Active, not recruiting | Premenstrual Dysphoric Disorder:Knowledge,Attitude and Practice Among Egyptian Females | March 15, 2022 | December 2022 | |
NCT00518570 | Completed | N/A | Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD) | November 2003 | October 2006 |
NCT00536198 | Completed | Phase 4 | Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder | November 6, 2007 | February 2012 |
NCT00620581 | Completed | Phase 3 | Luteal Phase Administration of Paroxetine for the Treatment of PMDD | ||
NCT00678574 | Completed | Phase 4 | The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder | March 1998 | December 2008 |
NCT00927095 | Completed | Phase 4 | Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD) | July 2008 | July 2014 |
NCT01799733 | Completed | N/A | Alternative Treatments for Premenstrual Dysphoric Disorder | June 18, 2013 | July 3, 2018 |
NCT03697265 | Completed | Phase 2 | A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD) | April 20, 2018 | October 23, 2020 |
NCT03862469 | Completed | N/A | Premenstrual Hormonal and Affective State Evaluation (PHASE) Project | September 26, 2019 | September 1, 2023 |
NCT06136104 | Completed | N/A | The Effects of Mixhers HERTIME Supplements on Menstrual Symptoms | August 30, 2023 | December 20, 2023 |
NCT01385709 | Completed | The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels | August 2008 | August 2013 | |
NCT01875718 | Completed | Phase 1/Phase 2 | A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD) | January 2013 | June 2014 |
NCT00516113 | Completed | Phase 4 | A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria | October 2000 | November 2002 |
NCT06227676 | Completed | Phase 2/Phase 3 | Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25 | July 21, 2022 | October 31, 2022 |
NCT02508103 | Completed | Phase 2/Phase 3 | Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study | July 2015 | July 2016 |
NCT03449979 | Completed | N/A | Single Session of tACS in a Depressive Episode | September 19, 2018 | August 16, 2019 |
NCT06462391 | Not yet recruiting | N/A | Adapting and Piloting Acceptance and Commitment Therapy (ACT) for Severe Premenstrual Mood Symptoms | July 1, 2024 | December 31, 2026 |
NCT05813366 | Not yet recruiting | N/A | Combined Effect of Tryptophan Rich Diet and Acupuncture on Depression Related to Premenstrual Dysphoric Disorder | April 25, 2023 | July 25, 2023 |
NCT05098574 | Recruiting | Phase 2 | Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder | November 30, 2022 | June 30, 2024 |
NCT00089414 | Terminated | Phase 2 | Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives | July 2004 | June 2010 |
NCT02362191 | Terminated | N/A | Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDD | March 2015 | March 2020 |
NCT02448836 | Unknown status | N/A | Deep Transcranial Magnetic Stimulation (dTMS) for the Treatment of Premenstrual Dysphoric Disorder (PMDD) | June 2015 | |
NCT01217775 | Unknown status | Phase 3 | Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder | March 2016 | July 2017 |
NCT04123483 | Withdrawn | Phase 4 | EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders | November 2019 | November 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D065446